REGENXBIO Inc.
RGNX
$6.72
$0.172.60%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 234.69M | 255.46M | 290.36M | 338.70M | 275.26M |
Total Receivables | 32.87M | 45.48M | 45.12M | 41.85M | 44.09M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 9.07M | 11.00M | 10.02M | 13.59M | 14.52M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.38M | 1.45M | 1.19M | 1.27M | 1.11M |
Total Current Assets | 278.00M | 313.40M | 346.68M | 395.42M | 334.97M |
|
|||||
Total Current Assets | 278.00M | 313.40M | 346.68M | 395.42M | 334.97M |
Net Property, Plant & Equipment | 171.31M | 175.84M | 180.31M | 185.22M | 192.59M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 6.50M | 6.77M | 5.44M | 6.77M | 7.54M |
Total Assets | 465.99M | 519.11M | 569.38M | 629.22M | 573.97M |
|
|||||
Total Accounts Payable | 22.80M | 19.52M | 16.36M | 31.36M | 22.79M |
Total Accrued Expenses | 37.91M | 48.31M | 42.35M | 32.98M | 49.32M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 42.21M | 34.42M | 39.40M | 45.68M | 57.64M |
Total Finance Division Other Current Liabilities | 271.00K | 478.00K | 158.00K | 162.00K | 534.00K |
Total Other Current Liabilities | 271.00K | 478.00K | 158.00K | 162.00K | 534.00K |
Total Current Liabilities | 103.19M | 102.73M | 98.27M | 110.18M | 130.27M |
|
|||||
Total Current Liabilities | 103.19M | 102.73M | 98.27M | 110.18M | 130.27M |
Long-Term Debt | 25.38M | 35.05M | 41.08M | 44.70M | 43.49M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 74.13M | 76.34M | 78.23M | 80.18M | 82.22M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.64M | 3.58M | 3.53M | 3.49M | 6.25M |
Total Liabilities | 206.34M | 217.70M | 221.11M | 238.55M | 262.23M |
|
|||||
Common Stock & APIC | 1.19B | 1.18B | 1.17B | 1.16B | 1.02B |
Retained Earnings | -932.15M | -880.96M | -821.37M | -768.38M | -705.05M |
Treasury Stock & Other | -741.00K | -582.00K | -2.27M | -3.23M | -4.43M |
Total Common Equity | 259.65M | 301.42M | 348.27M | 390.67M | 311.74M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 259.65M | 301.42M | 348.27M | 390.67M | 311.74M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 259.65M | 301.42M | 348.27M | 390.67M | 311.74M |
|